Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...
A Practical Guide for Advancing Brain Organoid Studies Cerebral organoids, derived from human pluripotent stem cells (hPSCs), have emerged as powerful thre | Ebooks ...
During a live event, Taha Al-Juhaishi, MD, discussed long-term outcomes of treating blastic plasmacytoid dendritic cell neoplasm and how to navigate toxicities and transplant.
Complementing previous work (Namiki et al, 2018), this study provides an important resource for the Drosophila community as it reports 500 lines targeting descending neurons (DN), in addition to ...
The enteric nervous system (ENS), the largest division of autonomic nervous system, is a tantalizing frontier in neuroscience. With the advent of single-cell transcriptomics, the ENS has been ...
Researchers in China have investigated four strategies that minimize TOPCon solar cell surface recombination centers and improve light trapping performance. They identified alkali polishing with micro ...
Mitochondrial dysfunctions are associated with a variety of pathologies, and the onset and progression of disease are accompanied by alterations in extracellular biochemical and mechanical signals.
The Balochistan government has decided to suspend cellular services across the province on 12 Rabi-ul-Awwal, which falls on September 6, to ensure peace and security during Eid Milad-un-Nabi (PBUH).
Activation of cell death pathways typically leads to the irreversible destruction of the cell. However, in this issue of The EMBO Journal, Dhar et al show that cells can recover from near-death states ...
Editor’s Note: To watch the full discussion about cellphones, students and schools on “Raising America,” click here. More and more U.S. students will be entering cellphone-free zones this year as ...
Genentech is continuing its summer of downsizing and cost-cutting, this time with plans to terminate a cell therapy deal worth as much as $2 billion. The pact is with Adaptive Biotechnologies and ...